ストックスクリーナーアプリを入手
19.17
0.47%
0.09
Kraneshares Msci All China Health Care Index Etf (KURE) 最新ニュース
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'CVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Trading the Move, Not the Narrative: (KURE) Edition - news.stocktradersdaily.com
KURE - KraneShares
(KURE) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
KraneShares MSCI All China Health Care Index ETF (NY: - FinancialContent
KraneShares SSE STAR Market 50 Index ETF (KSTR) stock price, news, quote and history - Yahoo! Finance Australia
Should EM Investors Trim or Retain Their China Exposure? - ETF Database
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Capitalize on China Healthcare Fundraising With KURE - ETF Database
Investing in Emerging Markets: CNXT, KSTR and More Top-Performing ETFs - NerdWallet
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
Mark Cuban Exposes How Wholesalers Force Pharmacies… - inkl
China Update: New IPOs, Healthcare Momentum, New Hydroelectric Dam - Seeking Alpha
China Thematic Update: New IPOs (KSTR), Healthcare Momentum From Regulatory Reprieve & Innovation (KURE), New Hydroelectric Dam (KGRN) - KraneShares
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
5 Biggest Pharmaceutical ETFs in 2025 - Nasdaq
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Mark Cuban Says Cutting PBM Fees Won't Reduce… - inkl
Long Term Trading Analysis for (KURE) - news.stocktradersdaily.com
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' - Benzinga
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - inkl
(KURE) Trading Signals - news.stocktradersdaily.com
7 Best China ETFs for July 2025 - NerdWallet
china growth - Syfe
KURE: Capitalizing on China’s Healthcare Revolution - KraneShares
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' - Yahoo Finance
Bank of America Corp DE Buys 22,248 Shares of Getty Images Holdings, Inc. (NYSE:GETY) - Defense World
Bank of America Corp DE Acquires 1,158 Shares of NACCO Industries, Inc. (NYSE:NC) - Defense World
Nektar Therapeutics (NASDAQ:NKTR) Shares Sold by Bank of America Corp DE - Defense World
Bank of America Corp DE Has $196,000 Holdings in Lakeland Industries, Inc. (NASDAQ:LAKE) - Defense World
Bank of America Corp DE Buys 1,088 Shares of Invesco Electric Vehicle Metals Commodity Strategy No K-1 ETF (NASDAQ:EVMT) - Defense World
4,793 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Acquired by Bank of America Corp DE - Defense World
Bank of America Corp DE Has $196,000 Stock Position in First Financial Northwest, Inc. (NASDAQ:FFNW) - Defense World
Bank of America Corp DE Lowers Stock Holdings in KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE) - Defense World
Humanoid Robotics ETF | KOID | Invest in the Future of Embodied AI - KraneShares
Learn to Evaluate (KURE) using the Charts - news.stocktradersdaily.com
KraneShares MSCI All China Health Care Index ETF (KURE) Short Interest Ratio and Volume 2025 - MarketBeat
Best Roth IRA Investments - NerdWallet
Jane Street Group LLC Takes $621,000 Position in KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE) - Defense World
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion - Benzinga
Top 4 ETFs for China Exposure After Tariff Relief | Stock Index | Business Insurance News, Analysis & Articles - FinancialContent
China's Healthcare ETFs Outpace U.S. Competitors - ETF Trends
3 ETFs Thriving in April’s Market Chaos—Are You Missing Out? - MarketBeat
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies - Benzinga
Six ETFs for investors seeking diversification outside North America - The Globe and Mail
New Drivers For China Healthcare: AI Med-Tech Innovation, Cancer Treatment, & Favorable Balance of Trade - KraneShares
China's Market Rebound: Is The NPC Meeting A Turning Point For Investors? - Benzinga
A KURE for China Tariff Concerns - ETF Trends
2025 China Outlook: A Recipe For Re-Rating - Forbes
7 Best Emerging-Market ETFs to Buy for 2025 - Money/ US News
Unlock China’s growth potential - Syfe
(KURE) Long Term Investment Analysis - news.stocktradersdaily.com
China's Bold Stimulus Measures: What It Means for Markets - home.saxo
KraneShares Launches AI-Powered China A-Share ETF (KCAI) - KraneShares
KCAI - KraneShares
KraneShares to close China healthcare and ESG leaders ETFs - ETF Stream
Best China ETFs to buy in 2024 - Dr Wealth
(KURE) Investment Report - news.stocktradersdaily.com
0.51%
大文字化:
|
ボリューム (24 時間):